Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
detroit blog main
detroit top stories
life sciences
national blog main
national top stories
5
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
5
×
seattle top stories
startups
5
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boulder/denver blog main
boulder/denver top stories
deals
eli lilly
indiana blog main
indiana top stories
national
abbvie
alzheimer's disease
cancer immunotherapy
clinical trials
johnson & johnson
merck
aduro biotech
agenus
biogen
What
companies
5
×
bio
roundup
drug
life
nash
news
price
admits
ago
alzheimer’s
approval
approved
big
biogen’s
biopharmaceutical
biotechs
black
classes
combinator
continue
convo
debut
diamond
diamond’s
different
digital
disease
dug
earlier
epidemic
fail
failures
fatty
fda
frenzied
gene
growing
increases
incubator
Language
unset
Current search:
companies
×
startups
×
" seattle blog main "
×
" national top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More